| CLBFX | DBALX | CLBFX / DBALX | |
| Total Expense Ratio | 0.67 | 0.93 | 72% |
| Annual Report Gross Expense Ratio | 0.67 | 0.93 | 72% |
| Fund Existence | 23 years | 10 years | - |
| Gain YTD | 2.357 | 1.923 | 123% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 5000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 270B | 279M | 96,774% |
| Annual Yield % from dividends | 2.08 | 2.58 | 81% |
| Returns for 1 year | 14.42 | 9.36 | 154% |
| Returns for 3 years | 38.39 | 21.37 | 180% |
| Returns for 5 years | 39.53 | 22.98 | 172% |
| Returns for 10 years | 105.76 | 73.58 | 144% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSQRX | 30.56 | 0.23 | +0.76% |
| Goldman Sachs Small Cap Value R | |||
| PPAJX | 22.38 | 0.13 | +0.58% |
| GMO U.S. Opportunistic Value R6 | |||
| TQVAX | 19.54 | 0.06 | +0.31% |
| T. Rowe Price Integrated US LCV Eq Adv | |||
| FSBDX | 23.37 | N/A | N/A |
| Fidelity Series Blue Chip Growth | |||
| NBGUX | 29.53 | -0.34 | -1.14% |
| Neuberger Large Cap Growth Adv | |||